3139 results for «906»
3139 results
Left main coronary interventions from basics to stenting techniques
15 May 2024 – From EuroPCR 2024
These EuroIntervention papers changed my practice!
15 May 2024 – From EuroPCR 2024
Bifurcation lesion, interactive case discussion
15 May 2024 – From EuroPCR 2024
An image is worth a 1,000 words
15 May 2024 – From EuroPCR 2024
Valve-in-valve
15 May 2024 – From EuroPCR 2024
TAV-in-TAV in complex situations
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on TAVI-in-TAVI procedures in complex situations. It covers various case presentations and discussions, including re-do TAVI with the risk of acute coronary obstruction, expanding possibilities in TAVR-in-TAVR with the mid-leaflet implantation technique, transcatheter valve-in-valve in self-expanding...
TAVI hotline: long-term registry data
15 May 2024 – From EuroPCR 2024
This session presents and discusses long-term registry data on various aspects of transcatheter aortic valve implantation (TAVI). It covers topics such as the surgical versus transcatheter approach in combined coronary and aortic valve disease, long-term outcomes of TAVI versus surgical aortic valve replacement, and registry data...
Which techniques to improve results of PCI in calcified lesions
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on techniques to improve PCI outcomes in calcified lesions. It covers various case presentations and discussions, including the use of imaging to guide therapy for calcified noduli, planning strategies for tortuous and calcified lesions, managing balloon-undilatable...
Renal interventions
15 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on renal interventions. It will cover various topics, including a novel approach to handle renal artery stenoses, an interesting case of paroxysmal nocturnal dyspnoea, accessory arteries in renal denervation and OCT, as well as renal denervation...
Unusual causes of acute coronary syndrome in the cathlab
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on unusual causes of acute coronary syndrome encountered in the catheterization laboratory. It covers various case presentations and discussions, including left main disease and STEMI in a young woman, STEMI secondary to antiphospholip syndrome, and Kawasaki...
Critical limb intervention
15 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on critical limb interventions. It will cover various topics, including successful revascularization treatment of Leriche Syndrome, techniques for creating loops, management of large thrombus in peripheral lesions with self-expandable stents, and the role of hybrid procedures.
Left main: presentation and diagnosis
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the presentation and diagnosis of left main coronary artery disease. It covers various case presentations and discussions, including isolated aortitis with critical coronary ostial stenosis due to Takayasu arteritis, acute left main occlusion, and critically...
When coronary physiology is crucial
15 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions where coronary physiology played a crucial role in the management of complex coronary cases. It will cover topics such as the appropriate use of physiology-guided PCI, the role of ultra-low-contrast PCI, and the management of unstable angina.
Vascular access complications following TAVI
15 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the management of vascular access complications following TAVI procedures. It will cover topics such as the management of a snapped single ProGlide, the use of distal femoral access to manage TAVI vascular complications, and the...
Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options
15 May 2024 – From EuroPCR 2024
In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...
Intracoronary imaging: diagnosis
16 May 2024 – From EuroPCR 2024
This session highlights the pivotal role of intracoronary imaging techniques, such as OCT and IVUS, in the diagnosis of various cardiovascular conditions. The presenters share case studies that demonstrate how these imaging modalities can help differentiate acute coronary syndrome from other conditions, identify the underlying causes...
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
TRILUMINATE pivotal: A landmark randomized clinical trial of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation
04 Mar 2023
Jonathan Curio and Alex Sticchi provide their take on this clinical trial which was presented by Paul Sorajja at the American College of Cardiology Scientific Session (ACC.23/WCC).
Author
Author
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
